Christian Berthou
Christian Berthou
EA2216, INSERM ERI29
Adresse e-mail validée de univ-brest.fr
TitreCitée parAnnée
A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia
V Lacronique, A Boureux, V Della Valle, H Poirel, CT Quang, ...
Science 278 (5341), 1309-1312, 1997
9121997
Maintenance therapy with thalidomide improves survival in patients with multiple myeloma
M Attal, JL Harousseau, S Leyvraz, C Doyen, C Hulin, L Benboubker, ...
Blood 108 (10), 3289-3294, 2006
7842006
Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials
N Boissel, MF Auclerc, V Lhéritier, Y Perel, X Thomas, T Leblanc, ...
Journal of Clinical Oncology 21 (5), 774-780, 2003
6042003
Comparison of 200 mg/m2 melphalan and 8 Gy total body irradiation plus 140 mg/m2 melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients …
P Moreau, T Facon, M Attal, C Hulin, M Michallet, F Maloisel, JJ Sotto, ...
Blood 99 (3), 731-735, 2002
5472002
Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support
N Milpied, E Deconinck, F Gaillard, V Delwail, C Foussard, C Berthou, ...
New England Journal of Medicine 350 (13), 1287-1295, 2004
4332004
Prospective comparison of autologous stem cell transplantation followed by dose-reduced allograft (IFM99-03 trial) with tandem autologous stem cell transplantation (IFM99-04 …
F Garban, M Attal, M Michallet, C Hulin, JH Bourhis, I Yakoub-Agha, ...
Blood 107 (9), 3474-3480, 2006
3982006
Imatinib plus peginterferon alfa-2a in chronic myeloid leukemia
C Preudhomme, J Guilhot, FE Nicolini, A Guerci-Bresler, F Rigal-Huguet, ...
New England Journal of Medicine 363 (26), 2511-2521, 2010
3792010
Essential role for the p110δ isoform in phosphoinositide 3-kinase activation and cell proliferation in acute myeloid leukemia
P Sujobert, V Bardet, P Cornillet-Lefebvre, JS Hayflick, N Prie, F Verdier, ...
Blood 106 (3), 1063-1066, 2005
2962005
Bortezomib plus dexamethasone versus reduced-dose bortezomib, thalidomide plus dexamethasone as induction treatment before autologous stem cell transplantation in newly …
P Moreau, H Avet-Loiseau, T Facon, M Attal, M Tiab, C Hulin, C Doyen, ...
Blood 118 (22), 5752-5758, 2011
2912011
Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT …
M Hunault, JL Harousseau, M Delain, M Truchan-Graczyk, JY Cahn, ...
Blood 104 (10), 3028-3037, 2004
2482004
A placebo-controlled study of recombinant human granulocyte-macrophage colony-stimulating factor administered during and after induction treatment for de novo acute myelogenous …
F Witz, A Sadoun, MC Perrin, C Berthou, J Brière, JY Cahn, B Lioure, ...
Blood 91 (8), 2722-2730, 1998
2041998
BAFF‐modulated repopulation of B lymphocytes in the blood and salivary glands of rituximab‐treated patients with Sjögren's syndrome
JO Pers, V Devauchelle, C Daridon, B Bendaoud, RL Berre, A Bordron, ...
Arthritis & Rheumatism 56 (5), 1464-1477, 2007
1972007
High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized …
E Gyan, C Foussard, P Bertrand, P Michenet, S Le Gouill, C Berthou, ...
Blood 113 (5), 995-1001, 2009
1752009
Thalidomide in patients with advanced multiple myeloma: a study of 83 patients--report of the Intergroupe Francophone du Myelome (IFM).
I Yakoub-Agha, M Attal, C Dumontet, V Delannoy, P Moreau, C Berthou, ...
The hematology journal: the official journal of the European Haematology …, 2002
164*2002
High-dose chemotherapy with autologous stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years: a multicenter phase II study …
P Colombat, A Lemevel, P Bertrand, V Delwail, P Rachieru, A Brion, ...
Bone marrow transplantation 38 (6), 417, 2006
1412006
Infectious diseases in the first year of life, perinatal characteristics and childhood acute leukaemia
N Jourdan-Da Silva, Y Perel, F Méchinaud, E Plouvier, V Gandemer, ...
British journal of cancer 90 (1), 139, 2004
1402004
Combination of quinine as a potential reversing agent with mitoxantrone and cytarabine for the treatment of acute leukemias: a randomized multicenter study
E Solary, B Witz, D Caillot, P Moreau, B Desablens, JY Cahn, A Sadoun, ...
Blood 88 (4), 1198-1205, 1996
1301996
Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation
X Thomas, H Dombret, C Cordonnier, A Pigneux, C Gardin, A Guerci, ...
Leukemia 14 (6), 1006, 2000
1192000
Cytogenetic abnormalities in adult acute lymphoblastic leukemia: correlations with hematologic findings and outcome: a collaborative study of the Groupe Francais de …
GF de Cytogénétique Hématologique
Blood 87, 3135-3142, 1996
1131996
Analysis of 18F-FDG PET diffuse bone marrow uptake and splenic uptake in staging of Hodgkin’s lymphoma: a reflection of disease infiltration or just inflammation?
PY Salaun, T Gastinne, C Bodet-Milin, L Campion, P Cambefort, ...
European journal of nuclear medicine and molecular imaging 36 (11), 1813-1821, 2009
1072009
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20